Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Recta...

Por Nogué, Miguel, Salud, Antonieta, Vicente, Pilar, Arriví, Antonio, Roca, José María, Losa, Ferran, Ponce, José, Safont, María José, Guasch, Inmaculada, Moreno, Isabel, Ruiz, Ana, Pericay, Carles
Publicado em 2011

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

Por García-Alfonso, Pilar, Ferrer, Ana, Gil, Silvia, Dueñas, Rosario, Pérez, María Teresa, Molina, Raquel, Capdevila, Jaume, Safont, María José, Castañón, Carmen, Cano, Juana María, Lara, Ricardo
Publicado no Target Oncol (2015)

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

Por Salazar, Ramon, Capdevila, Jaume, Laquente, Berta, Manzano, Jose Luis, Pericay, Carles, Villacampa, Mercedes Martínez, López, Carlos, Losa, Ferran, Safont, Maria Jose, Gómez, Auxiliadora, Alonso, Vicente, Escudero, Pilar, Gallego, Javier, Sastre, Javier, Grávalos, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique
Publicado no BMC Cancer (2015)

Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Tria...

Por Fernandez-Martos, Carlos, Brown, Gina, Estevan, Rafael, Salud, Antonieta, Montagut, Clara, Maurel, Joan, Safont, Maria Jose, Aparicio, Jorge, Feliu, Jaime, Vera, Ruth, Alonso, Vicente, Gallego, Javier, Martin, Marta, Pera, Miguel, Sierra, Enrique, Serra, Javier, Delgado, Salvadora, Roig, Jose V., Santos, Jesus, Pericay, Carles
Publicado em 2014